Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (229) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Pipeline (26) Apply Pipeline filter
- Corporate presentations (24) Apply Corporate presentations filter
- Shareholder meeting (23) Apply Shareholder meeting filter
- Team member (23) Apply Team member filter
- Videos (16) Apply Videos filter
- Financial reports (12) Apply Financial reports filter
- Webcasts and audio (12) Apply Webcasts and audio filter
- Analyst (11) Apply Analyst filter
- Investor contact (6) Apply Investor contact filter
- Event (4) Apply Event filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
SAR 421869 (Sanofi)
Gene therapy for Usher syndrome type 1B
Licensed to Sanofi: Phase I/IIa trial ongoing
Kymriah®* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
3rd CAR–T* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
4th CAR-T* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
OTL–201* (Orchard Therapeutics)
This is a partner product. Visit the relevant partner website for further information.
Other* (Orchard Therapeutics)
This is a partner product. Visit the relevant partner website for further information.
2nd CAR-T* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
CAR-T* (Beam)
This is a partner product. Visit the relevant partner website for further information.
CFTR gene (Boehringer / CFGTC)
This is a partner product. Visit the relevant partner website for further information.